Sanofi (SNY) reports 8 holdings worth $310.4M in 13F

Rhea-AI Filing Summary

Sanofi filed a Form 13F reporting its role as an institutional investment manager. The report lists 8 holdings with an aggregate market value of $310,414,825. The filing is signed by Alexandra Roger, Head of Legal Corporate & Finance, in Paris on 02-11-2026.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended: 12-31-2025

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	Sanofi
Address:	46 avenue de la Grande Armee
	Paris, I0 75017
Form 13F File Number:	028-25202
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:		Alexandra Roger
Title:		Head of Legal Corporate & Finance
Phone:		33 1 53 77 40 00
Signature, Place, and Date of Signing:
/s/ Alexandra Roger			Paris, I0	02-11-2026
[Signature]			[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:		0
	Form 13F Information Table Entry Total:		8
	Form 13F Information Table Value Total:		310,414,825
			(round to nearest dollar)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

NONE

FAQ

What does Sanofi's Form 13F filing disclose (SNY)?

Answer: The filing discloses that Sanofi reported 8 holdings with a total value of $310,414,825. The report is a routine institutional holdings disclosure signed on 02-11-2026 in Paris.

Who signed Sanofi's Form 13F and when?

Answer: The Form 13F is signed by Alexandra Roger, Head of Legal Corporate & Finance. The signature block shows the filing was signed in Paris on 02-11-2026.

How many holdings and what aggregate value are reported by Sanofi?

Answer: The report lists 8 holdings with an aggregate market value of $310,414,825, rounded to the nearest dollar as shown on the Form 13F summary page.

Does the Form 13F show other included managers for Sanofi?

Answer: The filing indicates NONE for other included managers. The Form 13F summary page shows Number of Other Included Managers: 0 and the manager reports all holdings in this report.

What is the purpose of a Form 13F filing like Sanofi's?

Answer: A Form 13F discloses an institutional manager's equity holdings as required by regulation. Sanofi's filing provides a snapshot of reported positions and an aggregate value of $310,414,825 as of the reporting period.